1-7 of 7
Debra Bergstrom
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Second Line Treatment and Outcomes of Patients with Multiple Myeloma: A Real World Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database

Arleigh McCurdy, Engin Gul, Donna Reece, Christopher P. Venner, Darrell White, Jiandong Su, Michael P. Chu, Victor H. Jimenez-Zepeda, Kevin Song, Hira Mian, Michael Sebag, Debra Bergstrom, Julie Stakiw, Anthony Reiman, Rami Kotb, Muhammad Aslam, Rayan Kaedbey, Martha L Louzada, Richard LeBlanc
Journal: Blood
Blood (2023) 142 (Supplement 1): 3364.
https://doi.org/10.1182/blood-2023-181138
Published: 2023
Journal Articles

Disease Characteristics and Outcomes of 504 Young Patients Diagnosed with Multiple Myeloma Treated with Modern Therapies in Canada

Mégane Tanguay, Jean Roy, Jiandong Su, Engin Gul, Donna Reece, Christopher P. Venner, Darrell White, Michael P. Chu, Victor H. Jimenez-Zepeda, Kevin Song, Arleigh McCurdy, Hira Mian, Michael Sebag, Debra Bergstrom, Julie Stakiw, Anthony Reiman, Rami Kotb, Muhammad Aslam, Rayan Kaedbey, Martha L Louzada, Richard LeBlanc
Journal: Blood
Blood (2023) 142 (Supplement 1): 1954.
https://doi.org/10.1182/blood-2023-174338
Published: 2023
Journal Articles

Impact of Maintenance Therapy after Salvage Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma

Rayan Kaedbey, Kevin Hay, Esther Masih-Khan, Moustafa Kardjadj, Arleigh McCurdy, Michael P. Chu, Victor H Jimenez-Zepeda, Richard Leblanc, Kevin Song, Hira S Mian, Martha L Louzada, Michael Sebag, Anthony Reiman, Darrell J White, Christopher P. Venner, Julie Stakiw, Rami Kotb, Muhammad Aslam, Debra Bergstrom, Engin Gul, Donna E. Reece
Journal: Blood
Blood (2022) 140 (Supplement 1): 10002–10004.
https://doi.org/10.1182/blood-2022-163661
Published: 2022
Journal Articles

Real-World Results of Autologous Stem Cell Transplantation in Newly Diagnosed Patients with Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database

Julie Cote, Richard Leblanc, Michael P. Chu, Arleigh McCurdy, Esther Masih-Khan, Moustafa Kardjadj, Victor H Jimenez-Zepeda, Kevin Song, Martha L Louzada, Hira S Mian, Darrell White, Michael Sebag, Anthony Reiman, Julie Stakiw, Rami Kotb, Debra Bergstrom, Muhammad Aslam, Rayan Kaedbey, Christopher P. Venner, Engin Gul, Donna E. Reece
Journal: Blood
Blood (2022) 140 (Supplement 1): 289–291.
https://doi.org/10.1182/blood-2022-158219
Published: 2022
Journal Articles

Real World Data on Outcomes of Anti-CD38 Antibody Refractory, Including Triple Class Refractory, Patients with Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database

Alissa Visram, Alfredo De La Torre, Darrell White, Moustafa Kardjadj, Esther Masih-Khan, Michael P. Chu, Victor H Jimenez-Zepeda, Arleigh McCurdy, Richard Leblanc, Kevin Song, Hira S Mian, Martha L Louzada, Michael Sebag, Debra Bergstrom, Julie Stakiw, Anthony Reiman, Rami Kotb, Muhammad Aslam, Christopher P. Venner, Rayan Kaedbey, Engin Gul, Donna E. Reece
Journal: Blood
Blood (2022) 140 (Supplement 1): 4287–4289.
https://doi.org/10.1182/blood-2022-168843
Published: 2022
Journal Articles

Selinexor Shows Synergy in Combination with Pomalidomide and Low Dose Dexamethasone in Patients with Relapsed / Refractory Multiple Myeloma

Christine Chen, MD, Rami Kotb, MD FRCPC., Michael Sebag, MD PhD, Richard LeBlanc, MD, Heather J. Sutherland, MD PhD, Darrell White, MD, Christopher P. Venner, MD, Tom Kouroukis, MD, Debra Bergstrom, BSc, MD FRCPC, Arleigh McCurdy, MD, Marc Lalancette, MDFRCP-C, William Bensinger, MD, Suzanne Lentzsch, MD PhD, Aldo Del Col, BSPharm, MBA, Michael Kauffman, MD PhD, Sharon Shacham, PhD MBA, Jacqueline Jeha, Carla Picklesimer, Jean-Richard Saint-Martin, Cassandra Choe-Juliak, MD, Nizar J. Bahlis, MD
Journal: Blood
Blood (2016) 128 (22): 3330.
https://doi.org/10.1182/blood.V128.22.3330.3330
Published: 2016
Journal Articles

Selinexor in Combination with Bortezomib and Dexamethasone (SdB) Demonstrates Significant Activity in Patients with Refractory Multiple Myeloma (MM) Including Proteasome-Inhibitor Refractory Patients: Results of the Phase I Stomp Trial

Nizar J. Bahlis, MD, Rami Kotb, MD FRCPC., Michael Sebag, MD PhD, Heather J. Sutherland, MD PhD, Richard LeBlanc, MD, Darrell White, MD, Christopher P. Venner, MD, Tom Kouroukis, MD, Debra Bergstrom, BSc, MD FRCPC, Arleigh McCurdy, MD, Marc Lalancette, MD FRCPC, William Bensinger, MD, Suzanne Lentzsch, MD PhD, Aldo Del Col, BSPharm, MBA, Michael Kauffman, MD PhD, Sharon Shacham, PhD MBA, Jacqueline Jeha, Carla Picklesimer, Jean-Richard Saint-Martin, Cassandra Choe-Juliak, MD, Christine Chen, MD
Journal: Blood
Blood (2016) 128 (22): 977.
https://doi.org/10.1182/blood.V128.22.977.977
Published: 2016